Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 98393
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98393
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98393
Figure 1 Study flow chart.
ERA: Early rituximab administration; LRA: Late rituximab administration.
- Citation: Kalashnikova E, Isupova E, Gaidar E, Lubimova N, Sorokina L, Chikova I, Kaneva M, Raupov R, Kalashnikova O, Aliev D, Gaydukova I, Kostik M. Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study. World J Nephrol 2024; 13(4): 98393
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/98393.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.98393